A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer

Clinical trial NCT00902291 · COMPLETED

Trial details

NCT number: NCT00902291
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Pancreatic Ductal Pancreatic Cancer Pancreatic Disease

Start date: 2009-04-01
Primary completion: 2012-04-01
Enrollment: 205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.